Logo image of FORA

FORIAN INC (FORA) Stock Fundamental Analysis

USA - NASDAQ:FORA - US34630N1063 - Common Stock

2.31 USD
0 (0%)
Last: 9/19/2025, 10:22:31 AM
2.11 USD
-0.2 (-8.66%)
After Hours: 9/5/2025, 8:15:33 PM
Fundamental Rating

4

Overall FORA gets a fundamental rating of 4 out of 10. We evaluated FORA against 35 industry peers in the Health Care Technology industry. FORA has a great financial health rating, but its profitability evaluates not so good. FORA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year FORA has reported negative net income.
In the past year FORA had a positive cash flow from operations.
In the past 5 years FORA reported 4 times negative net income.
In multiple years FORA reported negative operating cash flow during the last 5 years.
FORA Yearly Net Income VS EBIT VS OCF VS FCFFORA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

With a decent Return On Assets value of -7.58%, FORA is doing good in the industry, outperforming 62.86% of the companies in the same industry.
FORA's Return On Equity of -12.26% is fine compared to the rest of the industry. FORA outperforms 65.71% of its industry peers.
Industry RankSector Rank
ROA -7.58%
ROE -12.26%
ROIC N/A
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
FORA Yearly ROA, ROE, ROICFORA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

With a Gross Margin value of 60.76%, FORA perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
In the last couple of years the Gross Margin of FORA has grown nicely.
The Profit Margin and Operating Margin are not available for FORA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
FORA Yearly Profit, Operating, Gross MarginsFORA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

7

2. Health

2.1 Basic Checks

FORA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FORA has more shares outstanding
FORA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, FORA has an improved debt to assets ratio.
FORA Yearly Shares OutstandingFORA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
FORA Yearly Total Debt VS Total AssetsFORA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

FORA has an Altman-Z score of 1.63. This is a bad value and indicates that FORA is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.63, FORA is doing good in the industry, outperforming 62.86% of the companies in the same industry.
FORA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.3
Altman-Z 1.63
ROIC/WACCN/A
WACC9.23%
FORA Yearly LT Debt VS Equity VS FCFFORA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.50 indicates that FORA has no problem at all paying its short term obligations.
FORA has a Current ratio (2.50) which is in line with its industry peers.
A Quick Ratio of 2.50 indicates that FORA has no problem at all paying its short term obligations.
FORA's Quick ratio of 2.50 is in line compared to the rest of the industry. FORA outperforms 54.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.5
FORA Yearly Current Assets VS Current LiabilitesFORA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for FORA have decreased strongly by -178.00% in the last year.
FORA shows a decrease in Revenue. In the last year, the revenue decreased by -5.01%.
The Revenue has been growing slightly by 5.68% on average over the past years.
EPS 1Y (TTM)-178%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.25%
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%56.5%

3.2 Future

FORA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.28% yearly.
FORA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.73% yearly.
EPS Next Y151%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year48.18%
Revenue Next 2Y27.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FORA Yearly Revenue VS EstimatesFORA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
FORA Yearly EPS VS EstimatesFORA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

FORA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
FORA is valuated quite expensively with a Price/Forward Earnings ratio of 25.16.
77.14% of the companies in the same industry are more expensive than FORA, based on the Price/Forward Earnings ratio.
FORA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.88.
Industry RankSector Rank
PE N/A
Fwd PE 25.16
FORA Price Earnings VS Forward Price EarningsFORA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, FORA is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.45
EV/EBITDA N/A
FORA Per share dataFORA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

FORA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FORA's earnings are expected to grow with 66.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FORA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORIAN INC

NASDAQ:FORA (9/19/2025, 10:22:31 AM)

After market: 2.11 -0.2 (-8.66%)

2.31

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-14 2025-08-14/dmh
Earnings (Next)11-11 2025-11-11/amc
Inst Owners13.33%
Inst Owner Change-0.4%
Ins Owners51.93%
Ins Owner Change7.69%
Market Cap71.86M
Analysts82.86
Price Target5.1 (120.78%)
Short Float %0.58%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)50.98%
Min EPS beat(2)-30.72%
Max EPS beat(2)132.68%
EPS beat(4)2
Avg EPS beat(4)-30.72%
Min EPS beat(4)-292.16%
Max EPS beat(4)132.68%
EPS beat(8)5
Avg EPS beat(8)72.22%
EPS beat(12)9
Avg EPS beat(12)55.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.55%
Min Revenue beat(2)6.15%
Max Revenue beat(2)28.95%
Revenue beat(4)2
Avg Revenue beat(4)4.89%
Min Revenue beat(4)-10.98%
Max Revenue beat(4)28.95%
Revenue beat(8)3
Avg Revenue beat(8)0.29%
Revenue beat(12)5
Avg Revenue beat(12)-3.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)133.33%
EPS NY rev (1m)20%
EPS NY rev (3m)150%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)30.42%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)30.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.16
P/S 3.22
P/FCF 24.45
P/OCF 24.45
P/B 2.39
P/tB 2.49
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0.09
Fwd EY3.97%
FCF(TTM)0.09
FCFY4.09%
OCF(TTM)0.09
OCFY4.09%
SpS0.72
BVpS0.97
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.58%
ROE -12.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.76%
FCFM 13.16%
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.3
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.5
Altman-Z 1.63
F-Score4
WACC9.23%
ROIC/WACCN/A
Cap/Depr(3y)53.55%
Cap/Depr(5y)146.6%
Cap/Sales(3y)2.15%
Cap/Sales(5y)4.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-178%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.25%
EPS Next Y151%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%56.5%
Revenue Next Year48.18%
Revenue Next 2Y27.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-93.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y138.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.35%
OCF growth 3YN/A
OCF growth 5YN/A